Biochemical Engineering Special Interest Group
biological engineering professionals
28 June 2016

MilliporeSigma Inks Vaccine Manufacturing Deal with South Korean Institute

MilliporeSigma signed a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea, to help develop more scalable vaccine manufacturing processes. MilliporeSigma will provide funding and expertise in the areas of clarification and purification. Initially, the project will target a vaccine for typhoid, with the goal of applying findings to the manufacturing processes for pneumococcal, meningococcal, haemophilus, staphylococcus, streptococcus B, and other conjugated polysaccharide vaccines. Source: Genetic Engineering News 28/6/2016

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).